Navigation Links
Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys
Date:5/24/2011

MEMPHIS, Tenn., May 24, 2011 /PRNewswire/ -- Smith & Nephew Orthopaedics (NYSE: SNN) today announces the signing of a distribution agreement with French biotechnology company Graftys. The deal gives Smith & Nephew distribution rights for Graftys' fast-setting, macroporous calcium phosphate bone void filler in the U.S., and potentially in additional countries around the world.

"We are committed to offering our surgeon customers innovative solutions which benefit patients," says Bill Shopoff, President of the Trauma Franchise of Smith & Nephew Orthopaedics. "This is a unique product from the leading innovator in this space and we look forward to a successful partnership."

The distribution deal is for a unique bone graft technology that offers a surgeon an injectable, hard-setting resorbable calcium phosphate bone substitute which provides a support scaffold for bone growth and is also easy to mix and apply in situ.

"We are very confident that the combination of Graftys' unique technology with the broad capability of the Smith & Nephew organization will bring advanced capabilities to the orthopaedic marketplace," says Alain Valet, Chief Executive Officer for Graftys.

About Smith & Nephew

Smith & Nephew is a global medical technology business with global leadership positions in Orthopaedics; including Reconstruction, Trauma and Clinical Therapies; Endoscopy; including Sports Medicine; and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation
'/>"/>

SOURCE Smith & Nephew
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. GlaxoSmithKline Accelerates Review of Exelixis XL880
3. New Data Show That GlaxoSmithKlines Rotarix(R) Could Be Given With Other Routine Infant Vaccines in the U.S.
4. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
5. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
6. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
7. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
8. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
9. GlaxoSmithKline Announces New Drug Application and Phase III Results for Rezonic(TM)/Zunrisa(TM) (Casopitant)
10. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
11. GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015   Cochlear Limited ... hearing solutions, announced today the US Food and ... Profile™ Implant with Slim Straight Electrode (CI522). Built ... in close collaboration with the world,s leading surgeons, ... platform designed to provide the most discreet appearance ...
(Date:7/1/2015)... 24, 2015 ... the addition of the "2015 New ... Markets: Business Challenges, Emerging Technologies, Competitive Landscape" ... 2015 New Frontiers in European Clinical Chemistry ... Competitive Landscape is a new five-country strategic ...
(Date:7/1/2015)... July 1, 2015  goBalto, Inc., the leading ... today unprecedented growth in serving pharmaceutical, biotech and ... to speed clinical trials and restrain costs, but ... methods have stalled these efforts," said Sujay ... clinical trials has encouraged Industry leaders, to embrace ...
Breaking Medicine Technology:Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 2Cochlear Combines the World's Thinnest Cochlear Implant Platform with the Industry's Thinnest Full Length Electrode 32015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2
... 2011 Aerocrine, Inc., an innovative medical technology company ... has selected R&J Public Relations, LLC of Bridgewater, N.J., ... conduct strategic public relations for the Aerocrine brand; most ... and only hand-held device available to measure exhaled nitric ...
... Reportlinker.com announces that a new market research report ... Telemedicine: Opportunities for Medical and Electronic Providers ... global telemedicine market is expected to grow from $9.8 ... a compound annual growth rate (CAGR) of 18.6% over ...
Cached Medicine Technology:R&J Public Relations Named Agency of Record for Aerocrine, Inc. 2Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers 2Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers 3Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers 4Reportlinker Adds Telemedicine: Opportunities for Medical and Electronic Providers 5
(Date:7/2/2015)... ... ... DUI arrests and fatalities spike on the 4th of July. In fact, because of drunk ... comes to being on the road. According to attorney David J. Maloney , the ... highway deaths between 2007 and 2011 were caused by drunk driving over the 4th of ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... It’s no secret that what we consume can have an effect on ... people can easily feel dehydrated or perhaps even undernourished if not eating enough of the right ... can be an easy time of year to overdo it on the food front as well, ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... To Resource" for Semiconductor Timing announced the release and publication of their newest ... a Quarterly based publication and Newsletter. , Designed in support of coverage ...
(Date:7/1/2015)... Angeles, CA (PRWEB) , ... July 01, 2015 , ... ... the great outdoors. Yet, in many Middle-Eastern countries like Saudi Arabia and Dubai, the ... to relax in more temperate climates. Celebrity dentist Dr. Sam Saleh of ORA Dentistry ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... of Levaquin ( http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for Summary Judgment. ... West Virginia on June 26th, the Court rejected the Plaintiff’s assertion that ...
Breaking Medicine News(10 mins):Health News:Attorney David Maloney Stresses Safety through Sobriety 2Health News:Iryna Lobur Shares Healthy Treats to Eat for Summer 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 2Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 3Health News:Cs &A Releases the SEMI TIMING Newsletter Specific to the Semiconductor Timing Industry 4Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3
... Raises Caution on Using Signal Transduction Inhibitors,in Children -, ... eliminated brain tumors from mice in a dramatic 2004 ... damage in younger mice. The,researcher who conducted both studies ... drugs to treat children,s cancers, at,least until there is ...
... All Stages Steps Away From Home, ... ... of,South Carolina (MUSC) Foundation for Research and Development announced a,promising new ... cancer have shown to be accurate for only 40 percent of,diagnoses. ...
... DC (March 5, 2008): Addressing questions about climate change, ... in a recent survey, Student Pugwash USA launched From ... to the 2008 elections. , From Electrons to ... voters on science, technology, and health issues and provide ...
... CITY, March 10 ZARS Pharma, Inc. ... Galderma Pharma S.A. the,exclusive promotion and distribution ... and Canada for Pliaglis(TM) (lidocaine and tetracaine) ... and safe local,anesthesia in patients undergoing potentially ...
... Scientists have established a mouse model for human malignant ... development and progression along with new directions for design ... in the March issue of Cancer Cell, may eventually ... this devastating disease. , MM is an aggressive ...
... that can occur in babies with congenital heart disease is the ... results in too much blood in the lungs, more blood vessels ... vessel growth is abruptly halted. , You get this burst in ... think the system gets shut down and the lungs dont get ...
Cached Medicine News:Health News:Potential Brain Cancer Drug for Children May Damage Bones 2Health News:Potential Brain Cancer Drug for Children May Damage Bones 3Health News:Cell Receptor on Track for Painless Bladder Cancer Test 2Health News:Student Pugwash USA launches science policy election guide for young voters 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 3Health News:Mouse model for mesothelioma reproduces human disease 2Health News:Lung damage in babies with congenital heart disease under study 2Health News:Lung damage in babies with congenital heart disease under study 3
... PDA Closure Device has been developed for ... Arteriosus. Introduced through standard venous sheaths (10-14F) ... method for the percutaneous closure of persistent ... within the ductus.,An integral locking delivery and ...
Stainless steel plain Steinman Pins available in point types A through F....
Full pin skeletal traction pins with cove point....
Calibrated Guide Pins have a 12.7 mm calibration and are available in plain, with a threaded tip, or with a trocar point....
Medicine Products: